Akash Tewari

Q: What is Akash Tewari's success rate?

Akash Tewari currently has a success rate of 66.03885500792994.

Q: What is the average return of Akash Tewari's calls?

Their stock ratings have generated an average return of 33.18164708795242.

Stifel | Healthcare

Akash Tewari is an analyst from Stifel specializing in the Healthcare sector. Ranked #1539 out of 4700 analysts, they have issued 10 stock ratings with a success rate of 66.04% and an average return of 33.18%.

With 10 ratings to date, Akash Tewari is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 66.04% and an average return of 33.18%, highlighting promising potential as their track record develops further.

#1539

Out of 4700

Total Ratings

+66.04%

Success Rate

+33.18%

Average Return

Recent Ratings Analysis

APGE

Hold

Jun 24, 2026

Target

$135.00

Current

$132.68

Performance

-0.01%

Akash Tewari rated APGE as Hold on Jun 24, 2026, setting a price target of 135. The Hold stance appears justified, as shares hovered around 132.68 with a -0.01% move.

LLY

Buy

Jun 09, 2026

Target

$1350.00

Current

$1129.13

Performance

-1.30%

On Jun 09, 2026, LLY was given a Buy rating by Akash Tewari, with a target price of 1350. The stock traded sideways with a -1.30% move, keeping the bullish thesis unresolved.

SYRE

Buy

Apr 13, 2026

Target

$85.00

Current

$88.67

Performance

40.15%

SYRE received a Buy rating from Akash Tewari on Apr 13, 2026, aiming for 85. Momentum has favored the Buy call, with shares climbing from 88.67 to 88.67, rewarding those who trusted the recommendation.

AMGN

Hold

Mar 10, 2026

Target

$350.00

Current

$352.82

Performance

-6.02%

On Mar 10, 2026, Akash Tewari published a Hold outlook on AMGN, with a target of 350. Weakness in the stock, now at 352.82, supported the conservative rating.

GILD

Buy

Mar 10, 2026

Target

$180.00

Current

$123.84

Performance

-16.64%

Akash Tewari on Mar 10, 2026 assigned GILD a Buy rating, with a price target of 180. The call has struggled to gain traction, with shares losing 16.64%.

VRTX

Buy

Mar 10, 2026

Target

$580.00

Current

$480.18

Performance

-3.80%

On Mar 10, 2026, Akash Tewari reaffirmed VRTX with a Buy rating, targeting 580. Market indecision has kept the 580 target in a holding pattern.

BNTX

Buy

Mar 10, 2026

Target

$151.00

Current

$90.00

Performance

7.28%

BNTX was rated Buy by Akash Tewari on Mar 10, 2026, with a price objective of 151. A bullish response from the market helped close the gap of 61.00 to the target.

IONS

Buy

Sep 02, 2025

Target

$96.00

Current

$78.34

Performance

36.27%

On Sep 02, 2025, Akash Tewari initiated coverage on IONS with a Buy rating and target of 96. The stock’s climb of 36.27% since the call highlights the foresight in the rating.

REGN

Buy

Aug 27, 2025

Target

$831.00

Current

$620.14

Performance

5.65%

Akash Tewari issued a Buy recommendation for REGN on Aug 27, 2025, price target set at 831. Investors following the Buy call captured upside momentum, with shares now at 620.14.

CBIO

Buy

Aug 25, 2025

Target

$26.00

Current

$16.99

Performance

15.58%

On Aug 25, 2025, CBIO was evaluated by Akash Tewari, who gave a Buy rating and target of 26. This case illustrates how a timely bullish rating can translate into tangible gains of 15.58%.

BMY

Buy

Dec 16, 2024

Target

$70.00

Current

$55.39

Performance

-0.86%

Akash Tewari rated BMY as Buy on Dec 16, 2024, setting a price target of 70. Shares have remained stable near 55.39, leaving the 70 target still in play.

BMRN

Buy

Nov 15, 2024

Target

$95.00

Current

$57.35

Performance

-9.57%

On Nov 15, 2024, BMRN was given a Outperform rating by Akash Tewari, with a target price of 95. Despite the Buy call, shares fell from 57.35 to 57.35, challenging the optimistic stance.

NBIX

Buy

Aug 19, 2024

Target

$189.00

Current

$164.18

Performance

10.75%

NBIX received a Buy rating from Akash Tewari on Aug 19, 2024, aiming for 189. Momentum has favored the Buy call, with shares climbing from 164.18 to 164.18, rewarding those who trusted the recommendation.

APLS

Buy

Jul 31, 2024

Target

$80.00

Current

$41.03

Performance

3.61%

On Jul 31, 2024, Akash Tewari published a Buy outlook on APLS, with a target of 80. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 41.03.

Frequency Asked Questions

Who is Akash Tewari?

Akash Tewari is an analyst from Stifel specializing in the Healthcare sector.

What is Akash Tewari's success rate?

Akash Tewari currently has a success rate of +66.04%.

How many ratings has Akash Tewari issued?

Akash Tewari has issued 10 stock ratings so far.

What is the average return of Akash Tewari's calls?

Their stock ratings have generated an average return of +33.18%.

What is Akash Tewari's ranking?

Akash Tewari is ranked #1539 out of 4700 analysts.

What types of ratings does Akash Tewari give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Akash Tewari?

You can follow Akash Tewari by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Akash Tewari?

Their latest rating was a Hold on APGE issued on 2026-06-24.